SOCS4 and ovarian benign neoplasm: In the present study, immunohistochemistry revealed that expression of SOCS4 decreased significantly in EOC group (n = 38) compared to benign ovarian neoplasm group (n = 12) (p < 0.001; Figure 5D,F).